• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

区分低级别子宫内膜样腺癌和浆液性癌的策略。

Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.

机构信息

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Adv Anat Pathol. 2012 Jan;19(1):1-10. doi: 10.1097/PAP.0b013e318234ab36.

DOI:10.1097/PAP.0b013e318234ab36
PMID:22156830
Abstract

Distinction between endometrioid and serous carcinomas of the endometrium has important prognostic and therapeutic implications. Misdiagnosing a serous carcinoma as endometrioid can have significant consequences for the patient and pathologist. Although many cases are straightforward and easy to classify, there are occasional problematic cases. This review focuses on strategies that help differentiate between low-grade endometrioid carcinoma and serous carcinoma of the endometrium. We will discuss clinical, morphologic, and immunohistochemical differences between the 2 entities and provide practical tips for practicing pathologists when confronted with this differential diagnosis.

摘要

子宫内膜的子宫内膜样癌和浆液性癌之间的区别具有重要的预后和治疗意义。将浆液性癌误诊为子宫内膜样癌可能会对患者和病理学家产生重大影响。尽管许多病例是明确的且易于分类,但偶尔也会有棘手的病例。本综述重点讨论有助于区分低级别子宫内膜样癌和子宫内膜浆液性癌的策略。我们将讨论这两种实体之间的临床、形态和免疫组织化学差异,并为遇到这种鉴别诊断的病理学家提供实用技巧。

相似文献

1
Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.区分低级别子宫内膜样腺癌和浆液性癌的策略。
Adv Anat Pathol. 2012 Jan;19(1):1-10. doi: 10.1097/PAP.0b013e318234ab36.
2
HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.HMGA2 在子宫浆液性癌中普遍表达,是诊断的有用辅助手段。
Histopathology. 2012 Mar;60(4):547-53. doi: 10.1111/j.1365-2559.2011.04105.x. Epub 2012 Jan 17.
3
Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.p16 表达在鉴别子宫浆液性癌与子宫内膜样腺癌和宫颈内膜腺癌中的作用:201 例免疫组化分析。
Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.
4
IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.IMP2 表达可区分子宫内膜样癌与浆液性子宫内膜腺癌。
Am J Surg Pathol. 2011 Jun;35(6):868-72. doi: 10.1097/PAS.0b013e318219c6f9.
5
Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.子宫内膜癌:组织病理学分级和肿瘤细胞类型评估的争议。
J Clin Pathol. 2010 May;63(5):410-5. doi: 10.1136/jcp.2009.071225.
6
Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.浆液性与高级别子宫内膜样子宫内膜癌:RFP免疫组化对鉴别诊断无用。
Pol J Pathol. 2016;67(3):221-227. doi: 10.5114/pjp.2016.63773.
7
Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.子宫浆液性癌是否存在诊断不足?高级别子宫内膜癌最初诊断为高级别子宫内膜样癌时的组织形态学和免疫组织化学相关性及临床随访。
Mod Pathol. 2018 Feb;31(2):358-364. doi: 10.1038/modpathol.2017.131. Epub 2017 Oct 6.
8
Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.紧密连接蛋白1可区分子宫内膜样癌和浆液性乳头状子宫内膜腺癌。
Gynecol Oncol. 2006 Nov;103(2):591-8. doi: 10.1016/j.ygyno.2006.04.005. Epub 2006 Jun 22.
9
High-grade endometrial carcinomas - strategies for typing.高级别子宫内膜癌——分型策略。
Histopathology. 2013 Jan;62(1):89-110. doi: 10.1111/his.12029.
10
[Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma].
Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):849-53.

引用本文的文献

1
Construction of the prognostic nomogram and treatment recommendation in patients with mixed endometrial carcinoma treated with hysterectomy.子宫切除术治疗的混合性子宫内膜癌患者预后列线图的构建及治疗建议
Biomol Biomed. 2024 Dec 11;25(1):94-105. doi: 10.17305/bb.2024.10754.
2
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.子宫癌中 p53 状态对散发性错配修复缺陷和 Lynch 综合征的临床特征及影响。
Cancer Sci. 2024 May;115(5):1646-1655. doi: 10.1111/cas.16121. Epub 2024 Mar 3.
3
Nuclear Expression of β-Catenin Is Associated with Improved Outcomes in Endometrial Cancer.
β-连环蛋白的核表达与子宫内膜癌较好的预后相关。
Diagnostics (Basel). 2022 Oct 3;12(10):2401. doi: 10.3390/diagnostics12102401.
4
Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature review.恶性卵巢勃勒纳瘤与交界性黏液性囊腺瘤并存,合并原发性子宫内膜样子宫体癌:1例报告及文献复习
Oncol Lett. 2022 Jun 22;24(2):272. doi: 10.3892/ol.2022.13392. eCollection 2022 Aug.
5
The usefulness of intraoperative consultation for the diagnosis of borderline ovarian tumors.术中会诊对卵巢交界性肿瘤诊断的实用性。
Ann Transl Med. 2021 Feb;9(3):261. doi: 10.21037/atm-20-3932.
6
Endometrial Carcinomas with a "Serous" Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations.年轻女性的“浆液性”成分子宫内膜癌中富含错配修复缺陷、林奇综合征和 POLE 外切酶结构域突变。
Am J Surg Pathol. 2020 May;44(5):641-648. doi: 10.1097/PAS.0000000000001461.
7
Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma.一组免疫组织化学标志物在子宫内膜癌管理中的潜在作用
J Pathol Transl Med. 2019 May;53(3):164-172. doi: 10.4132/jptm.2019.02.12. Epub 2019 Feb 28.
8
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.子宫内膜癌诊断:国际妇产科病理学家学会关于在临床实践中使用国际妇产科联盟(FIGO)分级和基因组亚类的建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S64-S74. doi: 10.1097/PGP.0000000000000518.
9
Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.子宫低级别子宫内膜样癌(包括混合性子宫内膜癌)的鉴别诊断问题:国际妇科病理学家协会的建议
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S25-S39. doi: 10.1097/PGP.0000000000000512.
10
[Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].子宫内膜癌及其前驱病变的组织病理学诊断陷阱:临床相关鉴别诊断及避免假阳性诊断
Pathologe. 2016 Nov;37(6):512-520. doi: 10.1007/s00292-016-0236-y.